tradmap

PDSB Earnings PDS Biotechnology Corp

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$1 -$1 $0 2020 2021 2022 2023 2024 2025
EPS
Net income (annual)
-$51M -$25M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-373% 3986% 8344% 0% 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$1 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$11M -$5M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-189% 42% 272% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–26 of 26
Q2 20262026-06-30-0.312026-08-1310-Q
Q1 20262026-03-31-0.132026-05-1410-Q
FY 20252025-12-31-0.742026-03-3010-K
Q3 20252025-09-30-0.602025-11-1310-Q
Q2 20262025-06-30-0.412026-08-1310-Q
Q1 20262025-03-31-0.212026-05-1410-Q
FY 20252024-12-31-1.032026-03-3010-K
Q3 20252024-09-30-0.822025-11-1310-Q
Q2 20252024-06-30-0.532025-08-1310-Q
Q1 20252024-03-31-0.302025-05-1410-Q
FY 20242023-12-31-1.392025-03-2710-K
Q3 20242023-09-30-1.042024-11-1410-Q
Q2 20242023-06-30-0.692024-08-1310-Q
Q1 20242023-03-31-0.322024-05-1510-Q
FY 20232022-12-31-1.432024-03-2810-K
Q3 20232022-09-30-0.762023-11-1410-Q
Q2 20232022-06-30-0.502023-08-1410-Q
Q1 20232022-03-31-0.322023-05-1510-Q
FY 20222021-12-31-0.662023-03-2810-K
Q3 20222021-09-30-0.432022-11-1410-Q
Q2 20222021-06-30-0.162022-08-0810-Q
Q1 20222021-03-31-0.142022-05-1110-Q
FY 20212020-12-31-0.892022-03-3110-K
Q3 20212020-09-30-0.732021-11-1010-Q
Q2 20212020-06-30-0.542021-08-1210-Q
Q1 20212020-03-31-0.392021-05-1310-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.